+7-495-626-8046, +7-495-768-0434
понедельник-пятница, 10:00-18:00
Регистрация
|
+7-495-626-8046, +7-495-768-0434 понедельник-пятница, 10:00-18:00 |
Новости | Магазин | Журналы | Контакты | Правила | Доставка |
|
Вход Регистрация |
|||||
Представлено редкое клиническое наблюдение применения изолированной гипертермической химиоперфузии печени на фоне патологически измененного печеночного артериального кровотока при изолированном поражении печени метастазами увеальной меланомы. Продемонстрирована техническая возможность и безопасность проведения изолированной гипертермической химиоперфузии печени через воротную вену при измененном артериальном русле печени.
Ключевые слова:
печень, увеальная меланома, перфузия, воротная вена, трансартериальная химиоэмболизация, метастазы, liver, uveal melanoma, perfusion, portal vein, transarterial chemoembolization, metastases
Литература:
1.Michels N.A. Newer anatomy of liver-variant blood supply and collateral circulation. JAMA. 1960; 172 (2): 125-132. https://doi.org/10.1001/jama.1960.03020020005002
2.Sueyoshi E., Hayashida T., Sakamoto I., Uetani M. Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Am. J. Roentgenol. 2010; 195 (1): 245-251. https://doi.org/10.2214/AJR.08.2301
3.Belli L., Magistretti G., Puricelli G.P., Damiani G., Colombo E., Cornalba G.P. Arteritis following intra-arterial chemotherapy for liver tumors. Eur. Radiol. 1997; 7 (3): 323-326. https://doi.org/10.1007/s003300050159
4.Maeda N., Osuga K., Mikami K., Higashihara H., Onishi H., Nakaya Y., Tatsumi M., Hori M., Kim T., Tomoda K., Nakamura H. Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat. Med. 2008; 26 (4): 206-212. https://doi.org/10.1007/s11604-007-0216-5
5.Sakamoto I., Aso N., Nagaoki K., Matsuoka Y., Uetani M., Ashizawa K., Iwanaga S., Mori M., Morikawa M., Fukuda T., Hayashi K., Matsunaga N. Complications associated with trans catheter arterial embolization for hepatic tumors. Radiographics. 1998; 18 (3): 605-619. https://doi.org/10.1148/radiographics.18.3.9599386
6.NCI. National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) v5.0. 2017 [обновлено 21.09.2020, процитировано 18.10.2021]. Доступно: https://ctep.cancer.gov/protocol_Development/electronic_applications/ctc.htm.
7.Reddy S.K., Kesmodel S.B., Alexander H.R. Isolated hepatic perfusion for patients with liver metastases. Ther. Adv. Med. Oncol. 2014; 6 (4): 180-194. https://doi.org/10.1177/1758834014529175
8.van Iersel L.B., Verlaan M.R., Vahrmeijer A.L., van Persijn van Meerten E.L., Tijl F.G., Sparidans R.W., Gelderblom H., Kuppen P.J., Tollenaar R.A., van de Velde C.J. Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation. Eur. J. Surg. Oncol. 2007; 33 (7): 874-881. https://doi.org/10.1016/j.ejso.2007.02.022
9.Sigurdson E.R., Ridge J.A., Kemeny N., Daly J.M. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J. Clin. Oncol. 1987; 5 (11): 1836-1840. https://doi.org/10.1200/JCO.1987.5.11.1836
10.Rothbarth J., Pijl M.E., Vahrmeijer A.L., Hartgrink H.H., Tijl F.G., Kuppen P.J., Tollenaar R.A., van de Velde C.J. Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver. Br. J. Surg. 2003; 90 (11): 1391-1397. https://doi.org/10.1002/bjs.4308
11.van Iersel L.B., Hoekman E.J., Gelderblom H., Vahrmeijer A.L., van Persijn van Meerten E.L., Tijl F.G., Hartgrink H.H., Kuppen P.J., Nortier J.W., Tollenaar R.A., van de Velde C.J. Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases. Ann. Surg. Oncol. 2008; 15 (7): 1891-1898. https://doi.org/10.1245/s10434-008-9881-6
12.Jager M.J., Shields C.L., Cebulla C.M., Abdel-Rahman M.H., Grossniklaus H.E., Stern M.H., Carvajal R.D., Belfort R.N., Jia R., Shields J.A., Damato B.E. Uveal melanoma. Nat. Rev. Dis. Primers. 2020; 6 (1): 24. https://doi.org/10.1038/s41572-020-0158-0
13.Facy O., Doussot A., Zinzindohoue F., Holl S., Rat P., Ortega Deballon P. Isolated hepatic perfusion: principles and results. J. Visc. Surg. 2014; 151 (Suppl 1): S25-32. https://doi.org/10.1016/j.jviscsurg.2013.12.006
A rare clinical observation of using hyperthermic isolated hepatic chemoperfusion is considered in the setting of a pathologically altered hepatic arterial blood flow in focal hepatic lesions caused by uveal melanoma metastases. The technical feasibility and safety of performing hyperthermic isolated hepatic chemoperfusion through the portal vein against the background of the altered hepatic arterial bed were demonstrated.
Keywords:
печень, увеальная меланома, перфузия, воротная вена, трансартериальная химиоэмболизация, метастазы, liver, uveal melanoma, perfusion, portal vein, transarterial chemoembolization, metastases
